Cryptococcosis remains a significant cause of morbidity and mortality world-wide,
particularly among AIDS patients. Yet, to date, there are no licensed vaccines clinically …

Cryptococcosis is a fungal disease primarily occurring in immunocompromised individuals,
such as AIDS patients, and is associated with high morbidity and mortality. However …

Cryptococcus neoformans and C. gattii, the predominant etiological agents of
cryptococcosis, can cause life-threatening infections of the central nervous system in …

Cryptococcus neoformans, the predominant etiological agent of cryptococcosis, is an
encapsulated fungal pathogen that can cause fungal pneumonia and life-threatening …

Vaccines are one of the most effective public health tools to prevent and manage infectious
diseases. Since the first clinical use of vaccines in the late 18th century, many vaccines have …

Cryptococcus neoformans, the predominant etiological agent of cryptococcosis, is an
encapsulated fungal pathogen that can cause life-threatening infections of the central …

Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …

Cryptococcus neoformans, the predominant etiological agent of cryptococcosis, can cause
life-threatening infections of the central nervous system in immunocompromised and …

Cryptococcosis is a fungal disease caused by multiple Cryptococcus serotypes; particularly
C. neoformans (serotypes A and D) and C. gattii (serotypes B and C). To date, there is no …

Development of a vaccine to protect against cryptococcosis is a priority given the enormous
global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery …